Talk:Superoxide dismutase mimetics

GC4419 has clinical trial results
New drug could prevent debilitating side effect of cancer treatment says FDA has granted GC4419 breakthrough therapy status - but not sure what chemical category it is in. - Rod57 (talk) 11:18, 7 September 2018 (UTC)

MnTBAP does not work as a SOD mimetic
An article published in the Journal of Biological Inorganic Chemistry in 2008 shows that the pure MnTBAP does not have SOD mimetic activity. The SOD mimetic activity detected from the studies on MnTBAP were actually from impurities present on the Mn-porphyrin sample used.